Hepatitis B Vaccine
Review details immune responses in hepatitis B virus infection
Published in Hepatitis Weekly, April 21st, 2003
"Hepatitis B virus infection is one of the most frequent causes of chronic liver disease worldwide. Even though a preventive vaccine is available, the search for a cure for chronically infected patients remains a high priority to reduce the morbidity and mortality from liver cirrhosis and hepatocellular carcinoma," a scientist in the United States reports.
"This review summarizes the immune response in acute, self-limited and chronic hepatitis B; its differential effects on viral replication and liver injury; and prospects for immunotherapy," wrote Barbara Rehermann at the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-04-21)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Doctors urge certain hepatitis C virus nonresponders to undergo more therapy - Minority Health
Increased iron stores are a challenge to African-Americans with hepatitis C - Chronic Hepatitis C
More evidence hails RNA interference as a means for treating hepatitis C virus - Cirrhosis
A new scoring system predicts the risk for liver cancer in hepatitis patients - Inflammatory Disease
Researchers attribute transverse myelitis to chronic hepatitis C - Neuroscience
Cerebral dysfunction is a complication of chronic hepatitis C - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
